Susquehanna International Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,500
| Closed | -$223K | – | 13277 |
|
|
2025
Q4 | $223K | Sell |
5,500
-1,300
| -19% | -$56.6K | ﹤0.01% | 10632 |
|
|
2025
Q3 | $320K | Buy |
+6,800
| New | +$353K | ﹤0.01% | 9963 |
|
|
2024
Q4 | – | Sell |
-12,400
| Closed | -$892K | – | 12309 |
|
|
2024
Q3 | $892K | Buy |
+12,400
| New | +$875K | ﹤0.01% | 7063 |
|
|
2024
Q2 | – | Sell |
-21,600
| Closed | -$1.73M | – | 12158 |
|
|
2024
Q1 | $1.73M | Buy |
21,600
+5,700
| +36% | +$508K | ﹤0.01% | 5675 |
|
|
2023
Q4 | $1.74M | Sell |
15,900
-25,000
| -61% | -$2.58M | ﹤0.01% | 5663 |
|
|
2023
Q3 | $4.12M | Buy |
40,900
+2,100
| +5% | +$241K | ﹤0.01% | 3862 |
|
|
2023
Q2 | $5.27M | Buy |
38,800
+31,700
| +446% | +$3.87M | ﹤0.01% | 3437 |
|
|
2023
Q1 | $737K | Sell |
7,100
-51,100
| -88% | -$4.94M | ﹤0.01% | 7601 |
|
|
2022
Q4 | $5.16M | Buy |
58,200
+50,700
| +676% | +$4.21M | ﹤0.01% | 3180 |
|
|
2022
Q3 | $601K | Buy |
7,500
+4,600
| +159% | +$434K | ﹤0.01% | 7986 |
|
|
2022
Q2 | $278K | Buy |
2,900
+600
| +26% | +$72K | ﹤0.01% | 9768 |
|
|
2022
Q1 | $342K | Sell |
2,300
-4,700
| -67% | -$656K | ﹤0.01% | 9946 |
|
|
2021
Q4 | $992K | Buy |
7,000
+3,900
| +126% | +$552K | ﹤0.01% | 7319 |
|
|
2021
Q3 | $406K | Buy |
3,100
+1,100
| +55% | +$144K | ﹤0.01% | 9900 |
|
|
2021
Q2 | $275K | Sell |
2,000
-9,600
| -83% | -$1.31M | ﹤0.01% | 10961 |
|
|
2021
Q1 | $1.51M | Sell |
11,600
-2,400
| -17% | -$289K | ﹤0.01% | 6614 |
|
|
2020
Q4 | $1.57M | Sell |
14,000
-22,000
| -61% | -$2.08M | ﹤0.01% | 5633 |
|
|
2020
Q3 | $2.83M | Buy |
36,000
+20,600
| +134% | +$1.68M | ﹤0.01% | 3971 |
|
|
2020
Q2 | $1.11M | Buy |
15,400
+3,900
| +34% | +$271K | ﹤0.01% | 5679 |
|
|
2020
Q1 | $659K | Buy |
11,500
+9,200
| +400% | +$848K | ﹤0.01% | 6336 |
|
|
2019
Q4 | $257K | Sell |
2,300
-16,400
| -88% | -$1.75M | ﹤0.01% | 8313 |
|
|
2019
Q3 | $1.8M | Buy |
18,700
+5,400
| +41% | +$507K | ﹤0.01% | 4423 |
|
|
2019
Q2 | $1.14M | Buy |
13,300
+9,400
| +241% | +$773K | ﹤0.01% | 5360 |
|
|
2019
Q1 | $324K | Buy |
+3,900
| New | +$283K | ﹤0.01% | 7079 |
|
|
2018
Q3 | – | Sell |
-4,100
| Closed | -$300K | – | 9299 |
|
|
2018
Q2 | $300K | Sell |
4,100
-2,400
| -37% | -$163K | ﹤0.01% | 7847 |
|
|
2018
Q1 | $412K | Buy |
+6,500
| New | +$388K | ﹤0.01% | 7022 |
|
|
2017
Q4 | – | Sell |
-7,200
| Closed | -$378K | – | 9297 |
|
|
2017
Q3 | $378K | Buy |
+7,200
| New | +$361K | ﹤0.01% | 7011 |
|
|
2017
Q2 | – | Sell |
-17,300
| Closed | -$768K | – | 9244 |
|
|
2017
Q1 | $768K | Buy |
17,300
+10,000
| +137% | +$430K | ﹤0.01% | 5673 |
|
|
2016
Q4 | $322K | Sell |
7,300
-24,700
| -77% | -$1.05M | ﹤0.01% | 7833 |
|
|
2016
Q3 | $1.28M | Buy |
32,000
+22,500
| +237% | +$955K | ﹤0.01% | 4333 |
|
|
2016
Q2 | $453K | Buy |
+9,500
| New | +$402K | ﹤0.01% | 6292 |
|
|
2015
Q2 | – | Sell |
-6,500
| Closed | -$328K | – | 10118 |
|
|
2015
Q1 | $328K | Sell |
6,500
-3,700
| -36% | -$181K | ﹤0.01% | 7812 |
|
|
2014
Q4 | $459K | Sell |
10,200
-3,800
| -27% | -$159K | ﹤0.01% | 7381 |
|
|
2014
Q3 | $516K | Buy |
+14,000
| New | +$555K | ﹤0.01% | 7144 |
|
|
2013
Q3 | – | Sell |
-7,000
| Closed | -$219K | – | 8414 |
|
|
2013
Q2 | $219K | Buy |
+7,000
| New | +$227K | ﹤0.01% | 7299 |
|
Other funds holding CNMD
VPM
VCM
CB
Susquehanna International Group's CNMD Position: Q1 2026 in Review
Susquehanna International Group increased its CONMED (CNMD) stake by 200% in Q1 2026, buying an estimated $880K and bringing the position to 32,452 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #7525.
Susquehanna International Group first reported a position in CNMD in Q4 2013 and has held it in 41 quarters since. The position peaked at $2.93M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Susquehanna International Group held 32,452 shares of CONMED worth $1.15M as of Q1 2026.
- Susquehanna International Group bought 21,637 CONMED shares in Q1 2026, an estimated $880K.
- CONMED made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7525 holding.
- Susquehanna International Group first reported a position in CONMED in Q4 2013 and has held it in 41 quarters since.
- Susquehanna International Group's CONMED position peaked at $2.93M in Q4 2021.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.